1-3 of 3
Ukihide Tateishi, MD
Close
Sort by
Journal Articles

End-of-Treatment 18[F]-FDG PET Can Predict Progression-Free Survival in Patients Undergoing Bendamustine + Rituximab for First Relapsed/Recurrent Follicular Lymphoma: The Result of W- J H S NHL01 Study

Shinya Rai, MD PhD, Koji Kato, MD PhD, Junji Suzumiya, MD PhD, Koji Izutsu, MD PhD, Momoko Nishikori, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD PhD, Kenichi Yoshimura, PhD, Ukihide Tateishi, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tsutomu Takahashi, MD PhD, Takahiro Yamauchi, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5245.
https://doi.org/10.1182/blood-2019-126455
Published: 2019
Journal Articles

Post-Therapy 18 f-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome In Patients With Peripheral T-Cell Lymphomas

Naoto Tomita, MD, Yukako Hattori, MD, Shin Fujisawa, MD, Chizuko Hashimoto, MD, Jun Tguchi, MD, Hirotaka Takasaki, M.D., Rika Sakai, MD, Ukihide Tateishi, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2013) 122 (21): 4244.
https://doi.org/10.1182/blood.V122.21.4244.4244
Published: 2013
Journal Articles

Maximun Standard Uptake Value At the Biopsy Site During 18 f-Fluorodeoxyglucose Positron Emission Tomography Does Not Predict the Proliferation Potential of Tumor Cells in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Yoshimi Yamamoto, MD, Naoto Tomita, MD, Seiji Sakata, MD, Kengo Takeuchi, MD, Ukihide Tateishi, MD, Reina Watanabe, MD, Rika Sakai, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2011) 118 (21): 5216.
https://doi.org/10.1182/blood.V118.21.5216.5216
Published: 2011